Phenotypic Screen with the Human Secretome Identifies FGF16 as Inducing Proliferation of iPSC-Derived Cardiac Progenitor Cells.
Animals
CHO Cells
Cell Differentiation
/ drug effects
Cell Proliferation
/ drug effects
Cricetulus
Female
Fibroblast Growth Factors
/ classification
Fibroblasts
/ cytology
Gene Expression
Gene Library
High-Throughput Screening Assays
Humans
Induced Pluripotent Stem Cells
/ cytology
Mice
Mice, Inbred C57BL
Myocytes, Cardiac
/ cytology
Primary Cell Culture
cardiac progenitor cells
fibroblast growth factor 16
fibroblast growth factors
human secretome
phenotypic screening
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Nov 2019
30 Nov 2019
Historique:
received:
24
09
2019
revised:
22
11
2019
accepted:
27
11
2019
entrez:
6
12
2019
pubmed:
6
12
2019
medline:
17
4
2020
Statut:
epublish
Résumé
Paracrine factors can induce cardiac regeneration and repair post myocardial infarction by stimulating proliferation of cardiac cells and inducing the anti-fibrotic, antiapoptotic, and immunomodulatory effects of angiogenesis. Here, we screened a human secretome library, consisting of 923 growth factors, cytokines, and proteins with unknown function, in a phenotypic screen with human cardiac progenitor cells. The primary readout in the screen was proliferation measured by nuclear count. From this screen, we identified FGF1, FGF4, FGF9, FGF16, FGF18, and seven additional proteins that induce proliferation of cardiac progenitor cells. FGF9 and FGF16 belong to the same FGF subfamily, share high sequence identity, and are described to have similar receptor preferences. Interestingly, FGF16 was shown to be specific for proliferation of cardiac progenitor cells, whereas FGF9 also proliferated human cardiac fibroblasts. Biosensor analysis of receptor preferences and quantification of receptor abundances suggested that FGF16 and FGF9 bind to different FGF receptors on the cardiac progenitor cells and cardiac fibroblasts. FGF16 also proliferated naïve cardiac progenitor cells isolated from mouse heart and human cardiomyocytes derived from induced pluripotent cells. Taken together, the data suggest that FGF16 could be a suitable paracrine factor to induce cardiac regeneration and repair.
Identifiants
pubmed: 31801200
pii: ijms20236037
doi: 10.3390/ijms20236037
pmc: PMC6928864
pii:
doi:
Substances chimiques
FGF16 protein, human
0
Fibroblast Growth Factors
62031-54-3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Biol Chem. 2006 Jun 9;281(23):15694-700
pubmed: 16597617
Cell. 2018 Mar 22;173(1):104-116.e12
pubmed: 29502971
Mol Genet Genomic Med. 2014 Sep;2(5):402-11
pubmed: 25333065
Science. 2002 Dec 13;298(5601):2188-90
pubmed: 12481136
Mol Endocrinol. 2010 Oct;24(10):2050-64
pubmed: 20667984
Stem Cells Transl Med. 2016 Feb;5(2):164-74
pubmed: 26683871
Stem Cells Transl Med. 2019 Sep 11;:null
pubmed: 31508905
Circulation. 2017 Dec 12;136(24):2359-2372
pubmed: 29021323
Cell Stem Cell. 2011 Feb 4;8(2):228-40
pubmed: 21295278
PLoS Biol. 2006 Aug;4(8):e260
pubmed: 16869712
Development. 2016 Mar 15;143(6):936-49
pubmed: 26893347
Nat Methods. 2011 Sep 29;8(10):785-6
pubmed: 21959131
Science. 2011 Feb 25;331(6020):1078-80
pubmed: 21350179
Dev Dyn. 2008 Oct;237(10):2947-54
pubmed: 18816849
Nature. 2002 Dec 12;420(6916):636-42
pubmed: 12478285
J Exp Zool. 1974 Feb;187(2):249-53
pubmed: 4813417
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Cancer Cell. 2015 Oct 12;28(4):500-514
pubmed: 26461094
Appl Microbiol Biotechnol. 2018 Jan;102(2):605-613
pubmed: 29198068
Circulation. 2018 Dec 18;138(25):2931-2939
pubmed: 29991486
J Clin Invest. 2014 Mar;124(3):1382-92
pubmed: 24569380
Biochim Biophys Acta. 2013 Nov;1834(11):2454-61
pubmed: 23603790
Nat Biotechnol. 2019 Mar;37(3):232-237
pubmed: 30778231
Nat Med. 2014 Dec;20(12):1386-93
pubmed: 25473919
Biotechnol Prog. 2014 Jan-Feb;30(1):132-41
pubmed: 24106171
ACS Chem Biol. 2017 Jan 20;12(1):132-141
pubmed: 28103692
Circulation. 2019 Jul 9;140(2):164-166
pubmed: 31283370
Circ Res. 2019 Aug 16;125(5):552-566
pubmed: 31288631
Stem Cell Res. 2007 Nov;1(2):129-37
pubmed: 19383393
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W429-32
pubmed: 17483518
Nat Commun. 2015 May 18;6:6930
pubmed: 25980517
Nat Rev Drug Discov. 2017 Oct;16(10):699-717
pubmed: 28729726
Biochem Biophys Res Commun. 1998 Feb 4;243(1):148-52
pubmed: 9473496
Swiss Med Wkly. 2019 Jan 27;149:w20011
pubmed: 30685867
Mol Cell Biol. 1993 Jul;13(7):4251-9
pubmed: 8321227
Mol Ther Methods Clin Dev. 2018 Apr 10;9:330-346
pubmed: 30038937
Circ Cardiovasc Genet. 2012 Feb 1;5(1):o8-o18
pubmed: 22337932
Nat Biotechnol. 2013 Oct;31(10):898-907
pubmed: 24013197
J Biol Chem. 2017 Sep 15;292(37):15501-15511
pubmed: 28751379
Eur Heart J. 2017 Jan 14;38(3):201-211
pubmed: 28158410
Vascul Pharmacol. 2013 Mar;58(3):164-73
pubmed: 22902355
Nat Rev Cardiol. 2018 Oct;15(10):585-600
pubmed: 29872165
Proteomics. 2010 Mar;10(6):1141-9
pubmed: 20175080
Cardiovasc Toxicol. 2013 Sep;13(3):244-53
pubmed: 23430353
Circ Res. 2017 Mar 3;120(5):816-834
pubmed: 27908912
Bioinformatics. 2008 Dec 15;24(24):2928-9
pubmed: 18945683
Cell Rep. 2014 Feb 27;6(4):724-36
pubmed: 24529709
Circ Heart Fail. 2009 Nov;2(6):643-53
pubmed: 19919990